Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Boutoille

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Infection|July 21, 2015
Francisella tularensis aortitisM Briere, A Kaladji, F Douane, et al.
Journal of Clinical Microbiology|November 12, 2010
Clinical features of group B Streptococcus prosthetic joint infections and molecular characterization of isolatesS Corvec, M Illiaquer, S Touchais, et al.
Medecine Et Maladies Infectieuses|August 11, 2020
Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosisJ Brochard, F Morio, J Mahe, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 30, 2015
Simultaneous determination of ceftaroline, daptomycin, linezolid and rifampicin concentrations in human plasma by on-line solid phase extraction coupled to high-performance liquid chromatography-tandem mass spectrometryM Grégoire, A G Leroy, R Bouquié, et al.
Journal of Clinical Microbiology|March 4, 2011
First report of a hip prosthetic and joint infection caused by Lactococcus garvieae in a woman fishmongerG G Aubin, P Bémer, A Guillouzouic, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2016
Gram-negative prosthetic joint infections managed according to a multidisciplinary standardized approach: risk factors for failure and outcome with and without fluoroquinolonesO Grossi, N Asseray, C Bourigault, et al.
Medecine Et Maladies Infectieuses|June 28, 2011
[Measles in the Nantes Teaching Hospital during the 2008-2009 epidemic]C Biron, O Beaudoux, A Ponge, et al.
Medecine Et Maladies Infectieuses|December 1, 2009
[Contribution of molecular biology and Aspergillus galactomannan antigen assay for the diagnosis of histoplasmosis]S Pineau, J-P Talarmin, F Morio, et al.
Plos One|October 26, 2019
Incidence, characteristics, and mortality of infective endocarditis in France in 2011S Sunder, L Grammatico-Guillon, A Lemaignen, et al.
The Journal of Antimicrobial Chemotherapy|June 8, 2014
Switching from tenofovir/emtricitabine and nevirapine to a tenofovir/emtricitabine/rilpivirine single-tablet regimen in virologically suppressed, HIV-1-infected subjectsC Allavena, E Dailly, V Reliquet, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Infection|July 21, 2015
Francisella tularensis aortitisM Briere, A Kaladji, F Douane, et al.
Journal of Clinical Microbiology|November 12, 2010
Clinical features of group B Streptococcus prosthetic joint infections and molecular characterization of isolatesS Corvec, M Illiaquer, S Touchais, et al.
Medecine Et Maladies Infectieuses|August 11, 2020
Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosisJ Brochard, F Morio, J Mahe, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 30, 2015
Simultaneous determination of ceftaroline, daptomycin, linezolid and rifampicin concentrations in human plasma by on-line solid phase extraction coupled to high-performance liquid chromatography-tandem mass spectrometryM Grégoire, A G Leroy, R Bouquié, et al.
Journal of Clinical Microbiology|March 4, 2011
First report of a hip prosthetic and joint infection caused by Lactococcus garvieae in a woman fishmongerG G Aubin, P Bémer, A Guillouzouic, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2016
Gram-negative prosthetic joint infections managed according to a multidisciplinary standardized approach: risk factors for failure and outcome with and without fluoroquinolonesO Grossi, N Asseray, C Bourigault, et al.
Medecine Et Maladies Infectieuses|June 28, 2011
[Measles in the Nantes Teaching Hospital during the 2008-2009 epidemic]C Biron, O Beaudoux, A Ponge, et al.
Medecine Et Maladies Infectieuses|December 1, 2009
[Contribution of molecular biology and Aspergillus galactomannan antigen assay for the diagnosis of histoplasmosis]S Pineau, J-P Talarmin, F Morio, et al.
Plos One|October 26, 2019
Incidence, characteristics, and mortality of infective endocarditis in France in 2011S Sunder, L Grammatico-Guillon, A Lemaignen, et al.
The Journal of Antimicrobial Chemotherapy|June 8, 2014
Switching from tenofovir/emtricitabine and nevirapine to a tenofovir/emtricitabine/rilpivirine single-tablet regimen in virologically suppressed, HIV-1-infected subjectsC Allavena, E Dailly, V Reliquet, et al.
Pageof 6